EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Rapid Active–Latent–Relapse Murine Model of Tuberculosis Based Blood Transcriptional Signature That Distinguishes Disease Stages

Haifeng Li, Junfei Wang, Yu Wang, Fan Liu, Jun Tang, Mengmeng Sun, Lingjun Zhan iD

International Journal of Molecular Sciences · 11.03.2026 · 27 (6) · 2554

DOI: 10.3390/ijms27062554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.03.2026. Verfasst von Haifeng Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Laboratory Animal Science, CAMS & PUMC, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Chinese …. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Latent Tuberculosis, Transcriptome, Tuberculosis. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prevention and Control of Emerging and Major Infectious Diseas-es-National Science and Technology Major Project;CAMS Innovation Fund for Medical Sciences, Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project, Ministry of Science and Technology of China, and the CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The lack of reliable diagnostic tools and relapse monitoring for latent tuberculosis infection (LTBI) constitutes a major obstacle to global tuberculosis (TB) control. This highlights an urgent need for robust animal models and predictive biomarkers. To address this, we report the successful establishment of a rapid murine model of recapitulating the active, latent, and relapse phases of TB within a compressed ten-week timeframe—hence termed the rapid multi-stage TB murine model. In this model, mice were first intravenously infected with Mycobacterium tuberculosis, followed by a four-week isoniazid (INH) regimen starting at two weeks post-infection. By week six, pulmonary bacterial loads in most mice dropped below the detection limit, signifying the establishment of latency. Reactivation was subsequently triggered by a four-week administration of anti-TNF-α (Tumor Necrosis Factor-α) monoclonal antibody. Leveraging this reproducible and time-efficient model, we performed transcriptomic profiling of peripheral blood and identified a distinct sixteen-gene signature (including Ets2, Fam111a, Fosl2, Gadd45b, Nfkbid, Rgs1, Bhlhe40, Il1r2, Clec2d, Kmo, Lynx1, Papd4, Trim34a, Wrb, Nlrp12, Spns1) that dynamically tracks disease progression. Collectively, these findings not only provide a valuable and efficient preclinical tool but also deliver transformable candidate biomarkers with immediate potential to guide the development of novel diagnostic strategies for LTBI surveillance and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisLatent TuberculosisTranscriptomeTuberculosisAnimalsMiceDisease Models, AnimalGene Expression ProfilingRecurrenceBiomarkersIsoniazidFemaleDisease ProgressionAntitubercular Agents

Stichwörter der Autor:innen

Mycobacterium tuberculosisactive–latent–relapse murine tuberculosis modellncRNA sequencingtranscriptional signature

Substanzen

BiomarkersIsoniazidAntitubercular Agents

Autor:innen und Institutionen

  • Institute of Laboratory Animal Science, CAMS & PUMC, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Un…
  • National Center of Technology Innovation for Animal Model, Beijing 100021, China.
  • National Human Diseases Animal Model Resource Center, Beijing 100021, China.
  • State Key Laboratory of Respiratory Health and Multimorbidity, Beijing 100021, China.
  • Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College), Ministry of Education, Beijing 100021, China.
  • NHC Key Laboratory of Comparative Medicine, Beijing 100021, China.

ORCID-Profile: Lingjun Zhan

Förderung

  • Prevention and Control of Emerging and Major Infectious Diseas-es-National Science and Technology Major Project;CAMS Innovation Fund for Medical Sciences
  • Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project
  • Ministry of Science and Technology of China, and the CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Li, H., Wang, J., Wang, Y., Liu, F., Tang, J., Sun, M., & Zhan, L. (2026). A Rapid Active–Latent–Relapse Murine Model of Tuberculosis Based Blood Transcriptional Signature That Distinguishes Disease Stages. International Journal of Molecular Sciences, 27(6), 2554. https://doi.org/10.3390/ijms27062554

Vancouver

Li H, Wang J, Wang Y, Liu F, Tang J, Sun M, et al. A Rapid Active–Latent–Relapse Murine Model of Tuberculosis Based Blood Transcriptional Signature That Distinguishes Disease Stages. International Journal of Molecular Sciences. 2026;27(6):2554. doi:10.3390/ijms27062554

BibTeX
@article{Li2026,
  author = {Li, Haifeng and Wang, Junfei and Wang, Yu and Liu, Fan and Tang, Jun and Sun, Mengmeng and Zhan, Lingjun},
  title = {A Rapid Active–Latent–Relapse Murine Model of Tuberculosis Based Blood Transcriptional Signature That Distinguishes Disease Stages},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2554},
  doi = {10.3390/ijms27062554}
}
Kostenlos starten →